Introduction
The recombination of the immunoglobulin (Ig) genes during B-cell development is a key step in generating the repertoire of antibody diversity in the immune system, 1 and the large number of combinatorial possibilities of the different heavy-chain variable (V H ), diversity (D), and joining (J H ) gene segments in the Ig heavy-chain locus and light-chain variable (V L ) and joining (J L ) gene segments in the 2 light-chain loci constitute the base for this diversity. 2, 3 During V(D)J recombination, additional diversity is provided by random insertion/deletion of nucleotides in the D-J H , V H -DJ H , and V L -J L junctions and by the usage of 3 different reading frames for the D gene, hence creating the most hypervariable regions for antigen binding (ie, the heavy-and light-chain complementarity determining region 3 [CDR3] ). Furthermore, the final affinity maturation of the Ig molecules occurs in the germinal center during an antigen response, which can generate high-affinity antibodies by introduction of somatic hypermutation in the Ig gene rearrangements. Thus, the rearrangements of the Ig genes will provide each B-cell with a highly unique B-cell receptor (BCR) and can therefore serve as tumor markers in B-cell malignancies. 4 B-cell chronic lymphocytic leukemia (CLL) is the most common adult leukemia in Western countries and is characterized by a continuous expansion of CD5 ϩ /CD19 ϩ /CD23 ϩ monoclonal B cells. In this clinically heterogeneous disease, analysis of the somatic hypermutation status of the V H genes has proven to be a powerful prognostic predictor with mutated cases showing almost twice as long overall survival compared with patients with tumor cells lacking somatic hypermutation. [5] [6] [7] [8] [9] [10] Analysis of V H gene usage has revealed a biased repertoire with particular V H genes preferentially used compared with normal B cells, where the most prevalent are the V H 1-69, V H 3-07, V H 3-21, and V H 4-34 genes. 6, [11] [12] [13] [14] [15] [16] [17] [18] The V H 1-69 ϩ rearrangements in CLL were previously reported to display molecular peculiarities such as longer than average heavychain CDR3s (HCDR3s; ϳ19 amino acids) with skewed D3-3 and J H 6 gene usage compared with normal B cells. 13, 14, 17, 18 This finding of preferential V H , D, and J H gene usage as well as similar amino acid motifs in the HCDR3s in this subset of CLL led to the speculation of a possible antigen component involved in the pathogenesis of CLL with the hypothesis that BCRs encoded by specific V H DJ H combinations could generate Ig molecules with affinity to similar antigenic epitope(s). [13] [14] [15] Recently, we demonstrated that CLL cases with tumor cells rearranging the V H 3 family gene, V H 3-21, showed poor overall survival, 16, 18 which has also lately been confirmed by others. 19, 20 The V H 3-21 subset (ϳ11% of our CLL cohort) displayed predominantly mutated V H genes but still had an inferior clinical outcome and therefore did not fit into the prognostic classification scheme of mutated or unmutated CLL. 18 In addition, the V H 3-21 cases showed certain molecular characteristics with shorter than average HCDR3s (ϳ10 amino acids) and almost identical HCDR3 sequences with a conserved motif (ala-arg-asp-ala-asn-gly-met-asp-val) and a highly restricted usage of the V 2-14 gene in most cases. 16, 18 Considering that the CDRs of both the heavy-and light-chain V region comprise the antigen-binding site of the Ig molecule and that the HCDR3 is believed to contribute the most diversity in this respect, 21 the finding of similar HCDR3s coupled with V 2-14 gene usage indicated a common antigen-binding site in the BCRs of V H 3-21 ϩ CLL and suggested stimulatory influence of an unknown antigen in the disease development.
To further investigate signs of antigen selection in CLL, we studied the BCRs by analyzing the V H , D, and J H gene usage as well as performing multiple sequence alignment of the HCDR3 amino acid sequences obtained from 368 functional V H gene rearrangements amplified in 346 CLL cases. Furthermore, we carried out V L gene analysis in selected groups. Our data reveals further subsets of CLL with restricted HCDR3 features combined with preferential V L gene usage, thus indicating that BCRs with similar structures of the antigen-binding site were selected, which further corroborates the possibility of antigen involvement in CLL development.
Patients, materials, and methods

Patients and materials
Tumor samples were collected from 346 patients with CLL that had been identified from the archives of frozen tissue specimens at the University Hospitals of Uppsala (n ϭ 164), Linköping (n ϭ 79), Umeå (n ϭ 51), and Huddinge (n ϭ 19) in Sweden and at Tampere University Hospital (n ϭ 33) in Finland, between 1981 and 2001. Frozen tumor material was obtained mainly from peripheral blood and bone marrow but in a few cases also from lymph nodes, spleen, and other sources. Morphologic classification was performed according to the World Health Organization (WHO) classification, and tumor cells typically expressed CD5 and CD23 and had weak expression of Ig. 22 The median age at diagnosis was 65 years (range, 36-88 years) for the entire cohort, with a male-to-female ratio of 2:1.
PCR amplification and nucleotide sequence analysis
DNA was prepared from fresh-frozen tumor material using standard protocols including proteinase K treatment. V H and V L gene family-specific polymerase chain reaction (PCR) amplification was performed using consensus V H /J H primers and V L /J L primers as previously described. 23, 24 The sequence reactions were performed using either the BigDye Terminator Cycle Sequencing Reaction kit (Applied Biosystems, Foster City, CA) or the DYEnamic ET Dye Terminator Kit (Amersham Biosciences, Piscataway, NJ) and analyzed with an automated DNA sequencer (ABI 377 or ABI3700, Applied Biosystems; and MegaBACE 500 DNA Analysis System, Amersham Biosciences). The sequences were aligned to Ig sequences from the GenBank, 25 V-BASE, 26 and IMGT 27 databases. V H sequences deviating more than 2% from the corresponding germ line gene were defined as mutated. For D gene determination, a requirement of a minimum of 7 matching nucleotides was used. The length of the HCDR3 was calculated between codons 95 and 102 as previously described by Kabat. 28 All in-frame V H rearrangements were converted into amino acid sequences and the HCDR3 sequences were aligned in the multiple sequence alignment software Clustal X (1.83) for Windows (UBC Bioinformatics Centre, Vancouver, BC, Canada). Selection of V H groups with restricted HCDR3s was performed using the following criteria: (1) the group members had same V H gene usage, (2) the V H gene rearrangements showed at least 60% mean homology between the HCDR3s, and (3) the group contained at least 3 CLL cases. The numbering of cases in the figures and Table 1) . Of the 51 functional V H genes, 49 were represented in this material. Using the 2% mutation border, 146 (42%) cases were considered mutated with a mean mutation frequency of 5.8% (range, 2.1%-13.2%), and 200 (58%) cases were unmutated. In terms of mutated CLL cases, the most frequent V H gene rearranged was V H 3-21 (24 cases), whereas V H 1-69 (54 cases) represented the most frequent V H gene in unmutated cases (Table 1) . only.
For personal use at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From the unmutated rearrangements but in only 64% of the mutated rearrangements. The D genes D3-3, D2-2, and D6-19 represented 49% of the rearrangements in the unmutated V H gene rearrangements, whereas a more diverse spread was seen in the mutated rearrangements. J H 4 and J H 6 were the most frequently rearranged J H genes (71%, 287 of 365 identified J H genes; Figure 1 ) in both the mutated and unmutated subsets.
Identification of groups with restricted HCDR3 features and analysis of their V L gene usage
In this material, there were 13 different V H /D/J H combinations that were present in 3 or more cases (data not shown). However, considering that the preferential usage of certain V H /D/J H combinations does not necessarily indicate that the HCDR3s will show similarities at the amino acid level, since the D segment can be used in all 3 reading frames and as the rearrangements can display different N-regions, we decided to perform cluster analysis of the HCDR3 amino acid sequences only to identify subsets with restricted HCDR3 structures using a particular V H gene, as have been shown for the V H 3-21 group. Thus, the translated amino acid sequences of the HCDR3s from 368 functional V H gene rearrangements were collected into one file and multiple sequence alignment analysis was carried out. From this analysis, we could identify 4 groups using the V H 3-21 (22 cases), V H 1-69 (2 groups, 4 and 3 cases, respectively), and V H 1-2 (5 cases) genes with high similarities (75%-95% mean homology) in their HCDR3s (designated as "Groups with highly restricted HCDR3s"; see Table 2 ). In addition, another 3 groups with V H 1-3 (9 cases), V H 1-18 (3 cases), and V H 4-39 (5 cases) gene usage showed restricted features but with less HCDR3 homology (60%-75%; designated as "Groups with moderate HCDR3 homology"; see Table 2 ). The largest group contained 22 V H 3-21 cases with highly restricted HCDR3s, 19 of which have been published previously and will therefore not be shown further. 18 All amino acid sequences are illustrated in Figure  2 in their respective groups. None of the groups showed evidence of somatic hypermutation in their V H regions. The nucleotide sequences from the V H gene rearrangements are available in GenBank 25 at accession numbers AY486162-AY486231.
To investigate any association between V L gene usage and HCDR3 composition as in the V H 3-21 group, V L gene analysis was performed in these groups with high or moderate HCDR3s similarities. The nucleotide sequences from the V L gene rearrangements are available at GenBank 25 accession numbers AY490826-AY490888. Interestingly, the same rearranged V L gene was found in the majority of cases when coupled to a similar HCDR3 in the V H gene rearrangement (Figure 2 ).
Groups displaying highly restricted HCDR3s
V H 1-69 (2 groups). The first V H 1-69 group (4 cases) used a D3-16 and a J H 3 gene (Table 2 ) and displayed only 1 to 2 amino acid differences in the 18-amino acid-long HCDR3 sequence ( Figure  2A ). The D gene was used in the same reading frame and the HCDR3 showed identical lengths in all rearrangements. The N-segment in the V H /D junction consisted of 3 amino acids (except CLL27) and 2 amino acids were identical in all rearrangements, whereas 4 of 5 amino acids were the same in the D/J H junction. In one position, 1 amino acid difference was found between all rearrangements, which contained either an Asn, Tyr, His, or Asp amino acid, 3 of which have polar/hydrophilic properties. All 4 cases rearranged a V A27 gene combined with a J 1 or J 3 gene (Figure 2A ; Table 3 ). In addition to these cases, we identified from the public databases 4 other V H 1-69 ϩ CLL cases and 1 anticardiolipin antibody with highly similar HCDR3s. The differences between the HCDR3s in the 8 CLL cases were restricted to 2 positions in this 18-amino acid-long region (Figure 2A) .
The second V H 1-69 group (3 cases) rearranged a D3-3 and a J H 6 gene. The HCDR3 was 21 amino acids long and the same D gene reading frame was demonstrated. The D/J H junction contained 1 amino acid that was identical in all sequences (Figure 2A) , whereas the V H /D junction displayed higher variability with varying amino acid properties between the sequences. Two of the 3 cases rearranged a V 2-6 gene combined with a J 2 gene (Figure 2A ; Table 3 ), whereas the V L sequence was not determined in the remaining case (CLL72).
V H 1-2. The V H 1-2 group consisted of 5 cases using the D1-26 and J H 6 genes. These rearrangements displayed an identical D gene reading frame and identical HCDR3s lengths (14 amino acids; Figure 2A ). The V H /D and D/J H junctions consisted of only 1 amino acid each; 1 position was identical between the rearrangements, whereas the other position contained the same amino acid in 3 cases and different amino acids in the remaining 2 cases, all differences resulting in a hydrophobic amino acid. Three cases rearranged a V B3 gene joined with a J 2 or J 4 gene, whereas 1 case rearranged a V A17 gene, and in 1 case the V L usage was not determined (Figure 2A ; Table 3 ).
Groups displaying moderate HCDR3 homology
V H 1-3. Nine cases using the V H 1-3/D6-19/J H 4 genes displayed a mean of 65% homology between their HCDR3s, with 5 of 9 showing 70% to 80% homology (Table 2; Figure 2A ). The same D gene reading frame was used in all rearrangements and the HCDR3 had the same length in 7 of 9 cases. The V H /D junction (1 amino acid) was identical in 7 of 9 cases; however, more variability was indicated in the D/J H junction. Difference in the HCDR3s included amino acids with similar properties in 3 positions (1 in the V H /D junction and 2 in the D/J H junction), such as glu/asp/gln (all polar/hydrophilic), val/pro/gly/ala or ile/leu/met/phe/ala/pro (all non polar/hydrophobic), and 2 positions (both in the D/J H junction) with varying properties. All V L rearrangements used a V O2 gene together with a J 1 (4 cases), J 2 (4 cases), or J 4 (1 case) gene (Figure 2A ; Table 3) .
V H 1-18. Three cases were found to rearrange either a D6-19 (CLL57 and CLL56) or a D3-22 (CLL59) gene, all of which used a J H 4 gene ( Table 2) . Even though 2 different D gene segments were used, they resulted in a conserved 3-amino acid segment, Gln, Trp, and Leu, and the HCDR3s were of the same length in all 3 sequences ( Figure 2B ). The CDR3s showed 60% homology, but the N regions were less conserved and the different amino acids only.
For personal use at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From displayed varying properties. All 3 cases rearranged a functional V O2 with either a J 1, J 2, or J 3 gene ( Figure 2B ; Table 3) .
V H 4-39. Homology in the V H 4-39/D6-13-D6-19/J H 5 group varied between 62% and 75% in 5 cases ( Table 2 ). The D gene displayed the same reading frame, and the rearrangements had similar lengths of the HCDR3s despite differences in the V H /D and D/J H junctions ( Figure 2B ). In 3 positions (1 in the V H /D and 2 in the D/J H junction), 4 different amino acids were used in the separate sequences, with 2 positions (amino acid differences of Asp, Gly, Ser, or Ala and Thr, Asn, Gly, or Leu) showing differing properties and the third position (Arg, Ser, Thr, or Glu) having similar properties (polar/hydrophilic). Four of 5 cases rearranged a V O2 gene with either a J 2 or J 4 gene and the remaining case (CLL8) had a V A3/J 2 rearrangement ( Figure 2B ; Table 3 ).
Ig rearrangements with restricted HCDR3 features with low frequency
In addition to the above groups, a number of HCDR3s were found in sets of 2 sequences, which, because of their low frequency, are detailed separately. (Table 3) .
V L gene usage is restricted to HCDR3 composition
In order to study whether the restricted V L gene usage was linked to the HCDR3 composition or to the particular V H gene used, an additional 33 cases were analyzed by V L gene amplification within these groups using the same V H gene (V H 1-69, V H 4-39, V H 1-2, V H 1-3, and V H 1-18; Table  3 ). As illustrated in Figure 3 , a diverse usage of V L genes was found in 20 V H 1-69 using cases, and V L gene restriction was only demonstrated in cases with similar HCDR3s; the 4 V H 1-69/D3-16/J H 2 cases and the 2 V H 1-69/D3-3/J H 6 cases used a V A27 gene or a V 2-6 gene, respectively. These 2 V L genes were found in only 2 of the 14 other V H 1-69 cases without restricted HCDR3s and instead 7 different V and 3 different V genes were used. In the V H 4-39 cases, 12 of 16 were analyzed for V L gene usage, 4 of 5 cases with similar HCDR3s rearranged the V O2, whereas 7 other cases without HCDR3 homology rearranged 6 different V L genes (Table 3) . In the V H 1-2 cases, the 5 with restricted HCDR3s showed preferential V L gene use, whereas the 4 nonrestricted cases rearranged different V L genes: V O2, V L2, V L10, and V 1-17 (Table 3) . In the V H 1-3-using cases, 11 were analyzed with 9 showing restricted HCDR3s and a V O2 rearrangement, whereas the only.
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Discussion
Alignment analyses of the HCDR3s from 368 functional V H rearrangements revealed 3 subsets with highly similar HCDR3s (Ͼ 75% homology) as well as 3 subsets with moderate HCDR3 homology (60%-75%) in addition to the previously described V H 3-21 ϩ group. Our novel data are indicative of antigen selection in subsets of CLL, especially in the groups with highly similar HCDR3 features, but we also consider this possibility for the subgroups showing moderate HCDR3 homology. This interpretation is drawn from the following facts. Considering the probability that 2 V H DJ H rearrangements occur by chance is low (1/51 ϫ 1/27 ϫ 1/6 ϭ 1/8262), and in combination with a particular V L gene rearrangement very low (in combination with 1 V J , 1/8262 ϫ (1/40 ϫ 1/5) ϭ 1/1.6 million), these findings are unlikely to be a random phenomenon. Also, if the junctional diversity and the use of D reading frame is taken into account, the probability will diminish to less than 10 Ϫ12 . Furthermore, using a similar approach to analyze 227 HCDR3s from normal CD5 ϩ B cells available from the public databases (Genbank 25 ), similar rearrangements were demonstrated between only 2 sequences, indicating that our findings in CLL seem not to be a reflection of the normal B-cell repertoire (data not shown). 29, 30 This is in parallel with the finding of no duplicate Ig rearrangements in about 10 000 Ig sequences obtained from normal tonsils. 31 Further support to our data are also given by the previous reports showing CLL cases using the V H 1-69/D3-3/J H 6 genes or V H 4-39/ D6-13/J H 5 combinations with similar restriction of amino acid motifs within the HCDR3 as in our groups. 13, 32 We could also identify CLL rearrangements in the GenBank database 25 with similar sequences such as the 4 V H 1-69/D3-16/J H 3 rearrangements (db1-4; Figure 2A ), thus strengthening the finding of this particular subgroup. In parallel with our report, a recent abstract also showed combined V H /V L gene usage in V H 1-69, V H 3-21, V H 4-34, V H 1-2, and V H 1-3-using CLL with high HCDR3 homology. 33 Our study thus revealed indirect signs of antigen selection in subsets of CLL, but we cannot exclude that other CLL subgroups could exist that we have not been able to detect due to low frequencies in this material. Indeed, a number of small groups occurring in low frequency were identified using the V H 1-69, V H 4-34, and the V H 1-2 genes with restricted HCDR3 structures and also with similar light-chain rearrangements. A large-scale worldwide study of V H /V L gene rearrangements in CLL is now necessary in order to elucidate all different subgroups in detail and possible geographical differences. For instance, the V H 3-21 group has been shown in a higher frequency in Sweden compared with other large V H gene studies, which may indicate that regional difference between populations may be of importance. [34] [35] [36] Our data suggests a limited number of antigens involved in the selection of these BCRs; however, the identity of such antigens is currently unknown. These antigens could either be self-or non-selfantigens that may trigger and promote proliferation of B cells expressing certain BCRs, leading to clonal expansion and increased risk of transformation. The groups with high HCDR3 restriction, such as the V H 1-69 and V H 1-2 subgroups, showed limited variation between their HCDR3s with a higher likelihood that they could bind similar antigens, whereas this is less obvious in the moderatehomology groups that had further amino acid differences, although their restricted V H /D/J H and V L rearrangement may indicate antigen selection also within these groups. Interestingly, the recently described V H 4-39/V O2-expressing IgG ϩ CLL subset, with BCR structures similar to our V H 4-39 group, displayed comparable antigen-binding sites as monoclonal antibodies reacting toward bacterial carbohydrates as well as different autoantigens. 32 Furthermore, a V H 1-69/V A27 antibody obtained from a CLL patient showed low-affinity RF activity and bound to myoglobulin, thyroglobulin, actin, and ssDNA. 37 An anticardiolipin antibody encoded by a rearrangement similar to the V H 1-69/D3-16/J H 3 group in this study has also been indicated (GenBank 25 accession no. AAL67508), but no data were available concerning the V L gene usage. Moreover, the restriction of the HCDR3s found in our subgroups was mainly confined to the unmutated cases with poor prognosis. Recent data has shown that unmutated cases display a higher capacity to signal through their BCRs as measured by syk phosphorylation. 38 Signaling through the BCR may therefore play a vital role in the development and, perhaps, progression of the malignant clone in unmutated CLL. The restricted BCRs shown in groups with unmutated V H genes would hence indicate that a selected number of antigens could play an important role in the progression of the clonal expansion in the unmutated CLL subsets. Further studies of the binding sites of the restricted BCRs and putative antigens are now necessary to elucidate the possibility of antigen involvement in CLL development. TOBIN et al BLOOD, 1 NOVEMBER 2004 ⅐ VOLUME 104, NUMBER 9 only.
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